GO:0007042 lysosomal lumen acidification: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0007042 lysosomal lumen acidification is the biological process that lowers the pH inside lysosomes, creating the acidic environment required for hydrolytic enzyme activity and cellular degradation.
• The vacuolar H+-ATPase (V-ATPase) is the primary proton pump that acidifies the lysosomal lumen, while counter-ion channels and transporters modulate the electrochemical gradient.
• Lysosomal acidification is essential for autophagy, nutrient sensing, and cellular clearance, and its failure is linked to neurodegeneration, cancer, and lysosomal storage disorders.
• TMEM175 functions as a proton-activated proton channel that regulates lysosomal pH and is implicated in Parkinson's disease risk.
• Mitochondria can acidify lysosomes through membrane contacts, revealing inter-organelle communication in pH regulation.
• Experimental approaches to study lysosomal lumen acidification include live-cell pH imaging, genetic knockout of V-ATPase subunits, and CRISPR-based screens.
Description
Lysosomal lumen acidification (GO:0007042) is a fundamental biological process that maintains the acidic interior of lysosomes, typically pH 4.5–5.0, which is required for the optimal activity of acid hydrolases and for multiple cellular functions including autophagy, endocytosis, and nutrient signaling. This process is driven primarily by the vacuolar H+-ATPase (V-ATPase), a multi-subunit proton pump that translocates protons into the lysosomal lumen using ATP hydrolysis. Proper acidification is critical for cellular homeostasis, and its dysregulation has been linked to a growing list of human diseases, including neurodegenerative disorders such as Parkinson's disease and cancer. Researchers studying lysosomal biology need reliable tools to measure and manipulate lysosomal pH, and CRISPR-based gene editing offers powerful strategies to dissect the molecular machinery involved.
lysosomal lumen acidification At A Glance
| GO ID | GO:0007042 |
|---|---|
| GO term | lysosomal lumen acidification |
| Ontology | biological_process |
| Synonym | lysosome pH reduction |
| Major function | Reduces lysosomal luminal pH to activate acid hydrolases and support degradation, autophagy, and nutrient sensing |
| Key molecular players | V-ATPase, TMEM175, counter-ion channels (e.g., ClC-7), and organelle contact sites |
| Cellular context | Lysosomes, endolysosomal system, autophagy pathway |
| Disease relevance | Neurodegeneration (e.g., Parkinson's disease), cancer, lysosomal storage disorders |
| Research methods | Live-cell pH imaging, genetic knockout, CRISPR screens, proteomics |
What Is GO:0007042?
According to the Gene Ontology, lysosomal lumen acidification (GO:0007042) is defined as any process that reduces the pH of the lysosomal lumen, corresponding to an increase in hydrogen ion concentration. In other words, it encompasses the molecular mechanisms that pump protons into the lysosome to maintain its acidic environment, which is distinct from the lysosomal lumen itself (a cellular component) and from the catalytic activities of individual acid hydrolases.
Why Is lysosomal lumen acidification Important in Cell Biology?
Lysosomal lumen acidification is essential for the proper functioning of lysosomes, which serve as the cell's primary degradative compartments. The acidic environment is required for the activity of over 60 acid hydrolases that break down macromolecules, and it also regulates autophagy, membrane trafficking, and nutrient signaling. Disruption of lysosomal pH has been implicated in a wide range of pathologies, from neurodegenerative diseases to cancer, making it a critical area of biomedical research. Understanding the mechanisms and regulation of lysosomal acidification can reveal new therapeutic targets and biomarkers.
• Enables the activity of acid hydrolases, which require low pH for optimal function.
• Essential for autophagic flux and the clearance of damaged organelles and proteins.
• Regulates nutrient sensing pathways, including mTORC1 signaling.
• Maintains the electrochemical gradient necessary for lysosomal membrane transport.
• Dysregulation is linked to Parkinson's disease through proteins such as TMEM175.
• Lysosomal over-acidification can trigger cell death pathways, as shown in anaplastic thyroid cancer.
• A lysosomal surveillance response to stress can extend healthspan, highlighting its role in aging.
• Mitochondria-lysosome contact sites contribute to lysosomal acidification, revealing inter-organelle coordination.
• Targeting lysosomal acidification via V-ATPase is a strategy for overcoming lysosomal barriers in drug delivery.
• CRISPR-based models allow precise dissection of genes controlling lysosomal pH.
What Happens During lysosomal lumen acidification?
Proton pumping by V-ATPase
In simple terms: The V-ATPase acts like a molecular pump that uses energy to push protons into the lysosome, making it acidic.
The vacuolar H+-ATPase (V-ATPase) is a large multi-subunit complex that hydrolyzes ATP to transport protons across the lysosomal membrane against their concentration gradient. This primary active transport is the main driver of lysosomal acidification, establishing a pH gradient that can reach 2–3 units lower than the cytosol.
Counter-ion transport and charge balance
In simple terms: To keep the electrical balance, other channels allow ions to move in or out as protons are pumped in.
Proton pumping alone would create a positive membrane potential that opposes further acidification. Counter-ion channels and transporters, such as chloride channels (e.g., ClC-7) and cation channels, facilitate the movement of other ions to dissipate this potential and allow continued proton influx. TMEM175, a proton-activated proton channel, also contributes to lysosomal pH regulation by providing a proton leak pathway.
Regulation by organelle contacts
In simple terms: Lysosomes communicate with other organelles like mitochondria to fine-tune their acidity.
Recent evidence shows that mitochondria can acidify lysosomes through membrane contacts, indicating that inter-organelle communication plays a role in regulating lysosomal pH. This contact-dependent acidification may help coordinate cellular stress responses and metabolic state with lysosomal function.
Lysosomal surveillance and stress response
In simple terms: When lysosomes are stressed, a surveillance response helps maintain their function and can influence aging.
A lysosomal surveillance response to stress has been described that extends healthspan, involving the monitoring of lysosomal integrity and function, including acidification status. This response may trigger adaptive changes in lysosomal pH regulation to cope with stress.
Key Genes Involved in GO:0007042 lysosomal lumen acidification
The following genes and proteins are central to lysosomal lumen acidification, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ATP6V1A | V-ATPase V1 subunit A, catalytic ATP hydrolysis | Target for knockout to abolish acidification |
| ATP6V0A1 | V-ATPase V0 subunit a1, proton translocation | Mutations linked to neurodegeneration |
| ATP6V1B1 | V-ATPase V1 subunit B1 | Kidney and inner ear function; KO models |
| ATP6V0C | V-ATPase V0 subunit c | Essential for proton pore formation |
| TMEM175 | Proton-activated proton channel | Parkinson's disease risk gene; regulates lysosomal pH |
| CLCN7 | Chloride/proton antiporter | Counter-ion transport; osteopetrosis |
| OSTM1 | Associated with ClC-7 | Bone resorption and lysosomal function |
| LAMP1 | Lysosomal membrane protein | Marker for lysosomes; not directly acidifying |
| LAMP2 | Lysosomal membrane protein | Chaperone-mediated autophagy; Danon disease |
| mTOR | Nutrient sensor kinase | Regulates lysosomal function and biogenesis |
| TFEB | Transcription factor | Master regulator of lysosomal and autophagy genes |
| SNCA | Alpha-synuclein | Parkinson's disease; interacts with lysosomal membranes |
| LRRK2 | Leucine-rich repeat kinase 2 | Parkinson's disease; affects lysosomal function |
| GBA | Glucocerebrosidase | Lysosomal enzyme; mutations in Gaucher and Parkinson's |
| VPS35 | Retromer component | Endosomal sorting; Parkinson's disease |
| ATP13A2 | Lysosomal transporter | Kufor-Rakeb syndrome; Parkinsonism |
| TMEM106B | Lysosomal transmembrane protein | Frontotemporal dementia risk factor |
How Is lysosomal lumen acidification Regulated?
Lysosomal lumen acidification is regulated at multiple levels. The V-ATPase complex can be reversibly assembled/disassembled in response to nutrient availability, with mTORC1 signaling promoting V-ATPase assembly and activity. Transcription factor EB (TFEB) controls the expression of many lysosomal genes, including V-ATPase subunits, thereby influencing acidification capacity. Additionally, organelle contact sites with mitochondria can modulate lysosomal pH, and stress-responsive pathways such as the lysosomal surveillance response can adjust acidification to maintain cellular homeostasis.
lysosomal lumen acidification and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TMEM175 | Parkinson's disease | Knockout and point-mutation knock-in in neuronal cells |
| ATP6V0A1 | Neurodegeneration | Knockout in iPSC-derived neurons |
| GBA | Gaucher disease, Parkinson's disease | Point mutation knock-in (e.g., L444P) in macrophages |
| CLCN7 | Osteopetrosis | Knockout in osteoclasts |
| ATP13A2 | Kufor-Rakeb syndrome | Knockout in dopaminergic neurons |
Neurodegeneration
Failure of lysosomal acidification is increasingly recognized as a contributor to neurodegenerative diseases. In Parkinson's disease, risk variants in TMEM175 impair its proton channel function, leading to altered lysosomal pH and impaired clearance of alpha-synuclein. Disruption of endomembrane networks and lysosomal acidification has been observed in various neurodegenerative conditions, highlighting a common pathological mechanism.
Cancer
Lysosomal acidification can influence cancer cell survival and drug resistance. In anaplastic thyroid cancer, prosapogenin A induces GSDME-dependent pyroptosis through V-ATPase activation-mediated lysosomal over-acidification. Conversely, overcoming the lysosomal barrier via V-ATPase inhibition has been explored to enhance chemo/RNAi therapy in breast cancer.
Aging and healthspan
A lysosomal surveillance response to stress that extends healthspan underscores the importance of maintaining proper lysosomal acidification during aging. Interventions that bolster lysosomal function may promote longevity and delay age-related diseases.
From lysosomal lumen acidification-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of V-ATPase subunit abolish lysosomal acidification? | Knockout of ATP6V1A in HeLa or HEK293 cells |
| Does a Parkinson's risk variant in TMEM175 alter lysosomal pH? | Point mutation knock-in of TMEM175 variant in SH-SY5Y cells |
| Can overexpression of TFEB enhance lysosomal acidification? | Overexpression of TFEB in fibroblasts |
| What is the role of mitochondrial contacts in lysosomal pH? | Knockout of tethering proteins in HeLa cells |
| Does lysosomal over-acidification induce pyroptosis? | Overexpression of V-ATPase subunits in thyroid cancer cells |
| Can CRISPR screen identify new regulators of lysosomal pH? | Genome-wide CRISPR knockout library in reporter cells |
How to Study the lysosomal lumen acidification Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LysoSensor staining | Lysosomal pH | Rapid assessment of acidification in live cells |
| pHluorin-LAMP1 | Luminal pH of lysosomes | Dynamic pH measurements in response to stimuli |
| CRISPR knockout | Gene function | Testing necessity of candidate genes for acidification |
| RNA-seq | Transcriptional changes | Identifying pathways affected by pH alterations |
| Proteomics | Protein abundance and interactions | Mapping V-ATPase complex composition |
| Immunofluorescence | Lysosome morphology and marker localization | Assessing lysosomal integrity |
| CRISPR screen | Genome-wide gene function | Discovery of novel acidification regulators |
Live-cell pH imaging
Fluorescent probes such as LysoSensor and pH-sensitive GFP variants allow real-time measurement of lysosomal pH in living cells. These methods are essential for validating genetic perturbations and drug effects on acidification.
Genetic knockout and knockdown
CRISPR-Cas9 knockout of V-ATPase subunits or candidate genes, followed by pH measurement, can establish causality. Lentiviral shRNA knockdown provides an alternative for essential genes.
Proteomics and interactomics
Mass spectrometry-based proteomics can identify proteins associated with lysosomal membranes and reveal changes in V-ATPase assembly or post-translational modifications under different conditions.
CRISPR library screening
Genome-wide CRISPR knockout or activation screens using lysosomal pH reporters can uncover novel regulators of acidification. Such screens have been used to identify genes affecting lysosomal function and drug resistance.
How CRISPR Can Be Used to Study GO:0007042 lysosomal lumen acidification
Knockout
CRISPR-Cas9 knockout of genes such as ATP6V1A or TMEM175 can completely abolish or alter lysosomal acidification, providing a clean background to study downstream effects. Knockout cell lines are valuable for drug sensitivity assays and for validating targets identified in screens.
Point Mutation
Introducing disease-associated point mutations (e.g., TMEM175 variants) via CRISPR base editing or homology-directed repair allows researchers to study subtle changes in lysosomal pH regulation and their contribution to disease phenotypes.
Knock-in
Knock-in of tagged versions of V-ATPase subunits or pH reporters (e.g., pHluorin-LAMP1) enables real-time monitoring of lysosomal acidification in live cells without overexpression artifacts.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression can increase the levels of acidification regulators like TFEB or V-ATPase subunits, allowing gain-of-function studies and assessment of lysosomal over-acidification phenotypes.
How EDITGENE Supports lysosomal lumen acidification Research
Researchers studying lysosomal lumen acidification-related genes often need to determine whether a candidate gene is causally involved in maintaining lysosomal pH or whether its manipulation can modulate disease-relevant phenotypes. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for lysosomal lumen acidification research.
Frequently Asked Questions About lysosomal lumen acidification
What is lysosomal lumen acidification?
Lysosomal lumen acidification (GO:0007042) is the biological process that reduces the pH inside lysosomes, creating an acidic environment required for the activity of acid hydrolases and cellular degradation.
What genes are involved in lysosomal lumen acidification?
Key genes include V-ATPase subunits (e.g., ATP6V1A, ATP6V0A1), TMEM175, CLCN7, and regulators like TFEB and mTOR.
Why is lysosomal acidification important?
It is essential for the function of acid hydrolases, autophagy, nutrient sensing, and cellular clearance; its failure is linked to neurodegeneration and cancer.
How is lysosomal pH measured?
Live-cell imaging with fluorescent probes such as LysoSensor or pHluorin-LAMP1 allows real-time measurement of lysosomal pH.
What is the role of V-ATPase in lysosomal acidification?
V-ATPase is the primary proton pump that uses ATP to transport protons into the lysosomal lumen, driving acidification.
What is TMEM175 and how does it relate to lysosomal pH?
TMEM175 is a proton-activated proton channel in lysosomes that regulates pH and is linked to Parkinson's disease risk.
Can lysosomal acidification be targeted for cancer therapy?
Yes, both over-acidification and inhibition of acidification have been explored as therapeutic strategies in cancer.
What diseases are associated with defective lysosomal acidification?
Neurodegenerative diseases like Parkinson's, lysosomal storage disorders, and certain cancers.
How can CRISPR be used to study lysosomal acidification?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise manipulation of genes controlling lysosomal pH.
What services does EDITGENE offer for lysosomal acidification research?
EDITGENE provides knockout, point mutation, knock-in, overexpression cell models, CRISPR library screening, and bioinformatics services.
Conclusion
Lysosomal lumen acidification (GO:0007042) is a central biological process that sustains lysosomal function and cellular homeostasis. Its dysregulation contributes to neurodegeneration, cancer, and aging, making it a vibrant area of research. Advances in CRISPR-based gene editing and live-cell imaging are accelerating the discovery of new regulators and therapeutic targets. EDITGENE supports this research with tailored CRISPR models and screening services.
References
- 1. Mindell JA. 2012. Lysosomal acidification mechanisms.. Annu Rev Physiol 74:69-86 PMID: 22335796
- 2. Hu M et al.. 2022. Parkinson's disease-risk protein TMEM175 is a proton-activated proton channel in lysosomes.. Cell 185(13):2292-2308.e20 PMID: 35750034
- 3. Liu Y et al.. 2024. Prosapogenin A induces GSDME-dependent pyroptosis of anaplastic thyroid cancer through vacuolar ATPase activation-mediated lysosomal over-acidification.. Cell Death Dis 15(8):586 PMID: 39138191
- 4. Li TY et al.. 2025. A lysosomal surveillance response to stress extends healthspan.. Nat Cell Biol 27(7):1083-1097 PMID: 40571723
- 5. Ma L et al.. 2017. Live-cell Microscopy and Fluorescence-based Measurement of Luminal pH in Intracellular Organelles.. Front Cell Dev Biol 5:71 PMID: 28871281
- 6. Kim SH et al.. 2025. Failure of lysosomal acidification and endomembrane network in neurodegeneration.. Exp Mol Med 57(11):2418-2428 PMID: 41254240
- 7. Tian Z et al.. 2026. Mitochondria acidify lysosomes through membrane contacts.. Cell Rep 45(3):117112 PMID: 41838720
- 8. Liu K et al.. 2026. Overcoming lysosomal barrier via V-ATPase: an exosome-based co-delivery platform for combined chemo/RNAi therapy against breast cancer.. J Nanobiotechnology 24(1) PMID: 41896932
